**5. Conclusions**

This work aims to increase the number of substances available in the fight against infectious diseases and to combat the phenomenon of antibiotic resistance by promoting the use of alternative molecules in non-clinical settings (farms, food processing, airborne decontamination, etc.), preserving conventional antibiotics for clinical application in humans [17]. Worthy of further investigation is also a combination of approaches, combining *B. sacra* essential oils and conventional antibiotics against the global priority pathogens list of antibiotic-resistant bacteria.

**Author Contributions:** Conceptualization, L.R., V.D.S., D.S.; investigation, V.D.S., M.G.C., M.R.; data curation, L.R., V.D.S., D.S.; writing—original draft preparation, L.R.; writing—review and editing, V.D.S., D.S; funding acquisition, L.R. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research was funded by Dhofar University, Sultanate of Oman, gran<sup>t</sup> number DU/AY-2015-2016 FLAB-P002.2

**Acknowledgments:** The Board of Director and the Vice-Chancellor of Dhofar University are acknowledged for administrative support.

**Conflicts of Interest:** The authors declare no conflict of interest.
